Christian Chabannon, MD, PhD, Paoli-Calmettes Institute, Marseille, France, shares some insights into the EBMT Registry, which is monitoring the status of patients registered to be treated with CAR-T therapy in Europe, and aims to further develop studies to evaluate the efficacy and safety of these agents. This interview took place at the EBMT-EHA 5th European CAR T-cell Meeting held in Rotterdam, The Netherlands.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.